BC Platforms
Zurich, CH · Founded 2015 · Switzerland corporation · 3 known investors
Find your way into BC Platforms
20 people in our graph share verified history with the BC Platforms team — schools, employers, funds. One of them is your warm intro.
Joni Karsikasunlockedknows Nino da Silva · together at BC Platforms (overlapped)
×8knows the team · via IHM Business School
×2knows the team · via BC Platforms
knows the team · via BCB Medical
BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.
Founders & leadership
ND
Nino da SilvainManaging Director APAC, Global Lead Health Care & Partnership2025–2026Nino da Silva has held executive leadership roles including CEO and Managing Director with full P&L responsibility across healthcare and life sciences organizations in the US, Europe, Asia-Pacific, and the Middle East, and brings board experience as chair, director, and advisor.
TS
Tero SilvolainBoard Member2013–2025
MA
Mukhtar AhmedinChief Executive Officer
Board
HV
Hannu VaajoensuuBoard director
JH
Jari HeikkinenBoard director
EP
Erich PlatzerBoard director
MB
Mark BidwellBoard director
Investors · 3
Funding
SEC filings, press & company announcements$1.7M disclosed across 1 of 2 rounds · 2016–2022
- Undisclosed amountSeries CDec 2019Source ↗
▶$1.7MraisedDec 2016 · 3 investors · Other TechnologyRule 506(b)
▶$1.7MraisedDec 2016 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Hannu VaajoensuuDirector
- Jari HeikkinenDirector
- Nino da SilvaExecutive Officer
- Tero SilvolaExecutive Officer, Director
- Erich PlatzerDirector
- Mark BidwellDirector
- Offering amount
- $3M
- Amount sold
- $1.7M
- First sale
- Sep 2016
- Incorporated
- Corporation, Switzerland, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Labcorp10 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Iconplc7 shared keywordsICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.
Medidata7 shared keywordsMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
Companies competing with BC Platforms for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does BC Platforms do?
- BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.
- Who are BC Platforms's investors?
- BC Platforms's investors include Jolt Capital, StartAngels Network, Debiopharm Innovation Fund.
- How much funding has BC Platforms raised?
- BC Platforms has disclosed $1.7M raised across 1 of its 2 known rounds.
- Where is BC Platforms headquartered?
- BC Platforms is headquartered in Zurich, CH.